Rigel Pharma (RIGL) Could Rise Up to 90% Today - JP Morgan
- Top 10 News for 10/17 - 10/21: Merger Rumors Abound; CEOs Depart; Tesla Kicks Autopilot Up A Notch
- Wall Street ends little changed; Microsoft hits record
- AT&T (T) in Advanced Talks to Acquire Time Warner (TWX) - DJ
- Rockwell Automation (ROK) Said to Attract Takeover Interest from Schneider Electric - Source
- British American Tobacco Offers to Acquire Remaining Shares of Reynolds American (RAI) for $56.50/Share
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
JPMorgan is making positive comments on Rigel Pharma (NASDAQ: RIGL) following this morning's phase 3 data and said the stock could rise 60-90% today.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rigel Pharma (RIGL) Announced Second FIT Phase 3 of Fostamatinib Did Not Meet Primary Endpoint
- Chesapeake Energy (CHK) Looks to Add to Gains as Analysts Give Thumbs Up
- JPMorgan (JPM) names Orssten head of EMEA debt capital markets - Bloomberg
Create E-mail Alert Related CategoriesAnalyst Comments, FDA, Hot Comments, Momentum Movers, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!